Lentini Renee

Insider profile

Performance

Overall performance
1.1

Performance over holding periods
1.1
30 days 90 days 120 days
Average return -48% 8.2% 15.1%
Success rate 44% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Lentini Renee's trades of ImmunoGen Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-02-06 2024-02-05 PlS Planned sale
16,514 +5.8%
343.21
US$1,608,195
16,514 +5.8% 343.21 US$1,608,195
2024-02-05 2024-02-05 PrS Proposed sale
71,384
60.56
US$4,999,762
71,384 60.56 US$4,999,762
2023-12-27 2023-12-26 PlS Planned sale
71,515 -45.1%
219.79
US$710,987
71,515 -45.1% 219.79 US$710,987
2023-12-26 2023-12-26 PrS Proposed sale
6,548
29.74
US$194,761
6,548 29.74 US$194,761
2023-11-08 2023-11-06 S Sale
219,545 -100.0%
15.29
US$3,356,843
219,545 -100.0% 15.29 US$3,356,843
2023-11-06 2023-11-06 PrS Proposed sale
219,545
15.29
US$3,356,796
219,545 15.29 US$3,356,796
2023-08-04 2023-08-02 S Sale
148,277 -86.7%
17.55
US$2,602,261
148,277 -86.7% 17.55 US$2,602,261
2023-08-02 2023-08-02 PrS Proposed sale
148,277
17.55
US$2,602,499
148,277 17.55 US$2,602,499